13-May-2024
Rockwell Medical Q1 Earnings Preview
Seeking Alpha News (Mon, 13-May 1:34 PM ET)
Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States
Business Wire (Wed, 17-Apr 6:00 AM ET)
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
Business Wire (Tue, 16-Apr 6:00 AM ET)
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
Business Wire (Thu, 4-Apr 6:00 AM ET)
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
Business Wire (Mon, 25-Mar 6:00 AM ET)
Business Wire (Thu, 21-Mar 6:00 AM ET)
Universal Display Corporation Announces the Appointment of New Board Members
Business Wire (Thu, 7-Mar 4:05 PM ET)
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Rockwell Medical trades on the NASDAQ stock market under the symbol RMTI.
As of May 13, 2024, RMTI stock price climbed to $1.70 with 75,366 million shares trading.
RMTI has a beta of 2.77, meaning it tends to be more sensitive to market movements. RMTI has a correlation of 0.10 to the broad based SPY ETF.
RMTI has a market cap of $49.87 million. This is considered a Sub-Micro Cap stock.
Last quarter Rockwell Medical reported $22 million in Revenue and $.02 earnings per share. This fell short of revenue expectation by $-537,000 and exceeded earnings estimates by $.09.
In the last 3 years, RMTI stock traded as high as $11.66 and as low as $.84.
The top ETF exchange traded funds that RMTI belongs to (by Net Assets): VTI, VXF, IWC.
RMTI stock has underperformed the market in the last year with a return of -39.9%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RMTI shares. However, RMTI has outperformed the market in the last 3 month and 2 week periods, returning +30.8% and +16.8%, while SPY returned +4.3% and +2.5%, respectively. This indicates RMTI has been having a stronger performance recently.
RMTI support price is $1.57 and resistance is $1.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RMTI stock will trade within this expected range on the day.